Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

出版年份 2012 全文链接

标题

作者

关键词

Cancer treatment, Apoptosis, Melanoma cells, Antibody isotypes, Cell death, Melanomas, Immunohistochemistry techniques, Antibody therapy

出版物

Volume 7, Issue 9, Pages e45492

出版商

Public Library of Science (PLoS)

发表日期

2012-09-21

DOI

10.1371/journal.pone.0045492

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation